Sigma Nutrition Radio · Danny Lennon

#566: Can We Maintain Weight Loss? Pharmacology and Behavior – Tara Schmidt, RD

·51 min·5 clips
Tara Schmidt reveals why weight loss maintenance is actually more difficult than the initial weight loss phase.
This episode of Sigma Nutrition Radio features host Danny Lennon and registered dietitian Tara Schmidt from the Mayo Clinic, focusing on the challenges of long-term weight loss maintenance and the impact of GLP-1 medications. Schmidt, the lead dietitian for the Mayo Clinic Diet, brings clinical expertise in obesity and cardiovascular health to the discussion. The conversation critically examines what constitutes successful, clinically meaningful weight loss, such as a 5-10% reduction in body weight for improving metabolic health. Schmidt explains that weight loss maintenance is often more difficult than active weight loss due to physiological adaptations like increased hunger and a slowed metabolism. She references the National Weight Control Registry, identifying common behaviors among successful maintainers, including regular self-monitoring of weight and food intake. Research indicates maintainers often engage in 60-75 minutes of daily exercise, exceeding general guidelines, to counteract metabolic slowdown. The discussion highlights the tension between data supporting self-monitoring and potential psychological drawbacks or contraindications for some individuals. A key insight is that all diets promoting a calorie deficit can lead to initial weight loss, but long-term success hinges almost entirely on individual adherence and sustainability. Schmidt emphasizes creating personalized, non-branded habit lists for patients rather than prescribing rigid diet plans. The episode then explores how GLP-1 receptor agonist medications, like semaglutide, are changing the landscape by reducing "food noise" and cravings, facilitating adherence to lifestyle changes. These drugs can lead to 20-25% total body weight loss, rivaling bariatric surgery outcomes. Schmidt draws a direct parallel between nutritional counseling for patients on GLP-1s and those post-bariatric surgery, prioritizing protein, hydration, and nutrient-dense, low-volume meals. She notes that studies show one-half to two-thirds of lost weight is regained within a year if the medication is stopped, underscoring the need for long-term treatment strategies. The most common medication side effects are gastrointestinal, like nausea and constipation, related to delayed gastric emptying. The tone is educational and conversational, grounded in clinical practice and current research. This episode is ideal for healthcare practitioners, nutritionists, and individuals deeply interested in the science of obesity treatment. Listeners seeking a brief, motivational talk or those opposed to pharmacological interventions in weight management might find it less appealing.

As heard by us

A careful look at why losing weight and keeping it off are not the same problem.

This episode treats weight loss maintenance as a real-life problem, not a slogan. What makes it work is the focus on the ordinary friction points that decide whether a plan lasts: how food gets prepared, who is in the house, work, community, grocery access, and budget.

Read the full review in PlayNext →

Why you'd press play

You want a sober, practical take on weight loss maintenance and GLP-1s.

Read the full recommendation in PlayNext →
Listen to the show on